ArticleBMC health services research2025
PrEP demand creation strategies for adolescents at increased risk of HIV infection in São Paulo, Brazil: a cost-consequence analysis.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Challenges and Opportunities for Improved Tuberculosis and HIV Prevention in South America.Open forum infectious diseases · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe extension of PrEP coverage for vulnerable populations depends on demand creation strategies that aim to inform, encourage usage, and facilitate access to health services. However, there are no cost estimates for Brazil or Latin America regarding demand creation strategies focused on populations with higher vulnerability and risk of HIV infection. This analysis aims to assess the costs and health outcomes of different strategies used to create demand for PrEP for individuals aged 15 to 19 who identify as men who have sex with men (MSM), transgender women (TGW), or non-binary people assigned male at birth.
methodsCost-consequence analysis of six demand creation strategies used in the "PrEP1519 Study" (chatbot strategy; dating apps strategy; social media strategy; socialization places strategy; NGOs strategy; direct referrals strategy). The analysis was conducted using data from January 2019 to December 2021. The evaluated outcome was the "PrEP initiation ratio" (PrEPIR), which represents the percentage of approached individuals who started PrEP. The cost analysis included direct costs related to personnel, promotional materials, testing, equipment, and services.
resultsThe strategy with the highest PrEPIR was the social media strategy (2.97% [95% CI 2.29-3.84]), followed by the socialization places strategy (2.05% [1.45-2.89]). The direct referrals strategy, which served as the baseline, had one of the lowest PrEPIR (0.36% [0.30-0.43]). The average cost per participant included ranged from $100.74 for the direct referrals strategy to $5,572.00 for the chatbot strategy. The strategy with the highest total cost was the chatbot strategy ($55,719.98), whereas the strategy with the lowest total cost was the NGOs strategy ($10,809.80).
conclusionDespite incurring higher costs, the implementation of more successful demand creation strategies (such as socialization places, social media, and dating apps) has the potential to increase PrEP usage and, consequently, reduce HIV infection in populations facing greater vulnerability. These findings can contribute to more effective planning and organization of prevention programs by healthcare services to reach these populations.
trial registrationThis analysis is part of the "PrEP1519 Study" (protocol number 89993018.9.0000.0065).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.